Association analysis of dopamine D2-like receptor genes and methamphetamine abuse

Psychiatric Genetics

Volumn 14, Issue 4, 2004, Pages 223-226

  Chen, Chih Ken ^a,b   Hu, Xun ^a   Lin, Shih Ku ^c   Sham, Pak C ^a   Loh, El Wui ^a   Li, Tao ^a   Murray, Robin M ^a   Ball, David M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

Author keywords

Amphetamine related disorders; Genes; Methamphetamine; Psychoses; Psychotic disorders; Substance induced

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; METHAMPHETAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; TAIWAN; VARIABLE NUMBER OF TANDEM REPEAT;

FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHAMPHETAMINE; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE D2; SUBSTANCE-RELATED DISORDERS;

ADDITIVE WHITE GAUSSIAN NOISE (AWGN); MULTIPATH FADING CHANNELS; ORTHOGONALITY; SUBCARRIER FREQUENCIES;

ALGORITHMS; CHANNEL CAPACITY; DATA REDUCTION; FOURIER TRANSFORMS; FREQUENCIES; GAUSSIAN NOISE (ELECTRONIC); INFORMATION ANALYSIS; MAXIMUM LIKELIHOOD ESTIMATION; SIGNAL PROCESSING; SIGNAL RECEIVERS; WHITE NOISE;

ORTHOGONAL FREQUENCY DIVISION MULTIPLEXING;

EID: 3042595336     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200412000-00011     Document Type: Article

References (29)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorder-DSM-IV (4th edition). Washington, DC: American Psychiatric Association.
2. Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, et al. (2000). Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 32 (suppl):i-112.
3. Braff DL, Grillon C, Geyer MA (1992). Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215.
4. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK (1996), The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 88:91-101.
5. Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG (1998). Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry 155:1214-1220.
6. Collier DA, Curran S, Asherson P (2000). Mission: not impossible? Candidate gene studies in child psychiatric disorders [editorial]. Mol Psychiatry 5: 457-460.
7. Comings DE, Blum K (2000). Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 126:325-341.
8. Duaux E, Gorwood P, Griffon N, Bourdel MC, Sautel F, Sokoloff P, et al. (1998). Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol Psychiatry 3:333-336.
9. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, et al. (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 12:78-80.
10. Franke P, Nothen MM, Wang T, Knapp M, Lichtermann D, Neidt H, et al. (2000). DRD4 exon III VNTR polymorphism-susceptibility factor for heroin dependence? Results of a case-control and a family-based association approach. Mol Psychiatry 5:101-104.
11. Grandy DK, Zhang Y, Civelli O (1993). PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 2:2197.
12. Grove WM, Eckert ED, Heston L, Bouchard TJ Jr, Segal N, Lykken DT (1990). Heritability of substance abuse and antisocial behavior: a study of monozygotic twins reared apart. Biol Psychiatry 27:1293-1304.
13. Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, et al. (1997). Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 2:251-254.
14. Krebs MO, Sautel F, Bourdel MC, Sokoloff P, Schwartz JC, Olie JP, et al. (1998). Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol Psychiatry 3:337-341.
15. 2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 31:321-328.
16. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jonsson E, et al. (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2:249-256.
17. Li T, Xu K, Deng H, Cai G, Liu J, Liu X, et al. (1997). Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol Psychiatry 2:413-416.
18. Li T, Zhu ZH, Liu X, Hu X, Zhao J, Sham PC, Collier DA (2000). Association analysis of polymorphisms in the DRD4 gene and heroin abuse in Chinese subjects. Am J Med Genet 96:616-621.
19. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, et al. (1998). Familial transmission of substance use disorders. Arch Gen Psychiatry 55:973-979.
20. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859.
21. Persico AM, Bird G, Gabbay FH, Uhl GR (1996). D2 dopamine receptor gene Taql A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry 40:776-784.
22. Pickens RW, Svikis DS (1991). Genetic influences in human substance abuse. J Addict Dis 10:205-213.
23. Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M, et al. (1999). The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci 19:4627-4633.
24. Shaikh S, Collier D, Kerwin RW, Pilowsky LS, Gill M, Xu WM, Thornton A (1993). Dopamine D4 receptor subtypes and response to clozapine [Letter] [see comments]. Lancet 341:116.
25. Sham PC, Curtis D (1995). Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
26. Snyder SH (1973). Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines. Am J Psychiatry 130:61-67.
27. Tsai SJ, Cheng CY, Shu LR, Yang CY, Pan CW, Liou YJ, Hong CJ (2002). No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males. Psychiatr Genet 12: 29-33.
28. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, et al. (1996). Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet 67:473-477.
29. Wong AH, Buckle CE, Van Tol HH (2000). Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 410:183-203.